Ondansetron OD Tabs4 mg / 30 Count
Back to Products
Brand name: Zofran ODT®
1 Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2.
2 Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
3 Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen.
4 Prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, ondansetron orally disintegrating tablets, USP are recommended even where the incidence of postoperative nausea and/or vomiting is low.
For more information please see the prescribing information on DailyMed.
|Product Name||Ondansetron OD Tabs|
|Dosage Form||Orally Disintegrating Tablets|
|Pack Size||30 Count|
|Color||White (White To Off-White)|
|Gluten||Free from Gluten|
|Soy||Free from Soy|
|Gelatin||Free from Gelatin|
|Allergen Info||Free from Sulfphur, Nuts, and Eggs|
|Other Product Info||Guarana, Strawberry Flavor|
Mannitol, crospovidone, lactose monohydrate, cellulose microcrystalline, aspartame, silicon dioxide, magnesium stearate
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP
|Product Shelf Life||24 Months|
*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.